Genenta Science S.p.A.
GNTA
$3.84
-$0.0867-2.21%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -17.22% | -10.33% | -5.03% | 16.32% | 43.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.70% | -10.56% | 9.99% | 51.31% | 122.13% |
| Operating Income | 28.70% | 10.56% | -9.99% | -51.31% | -122.13% |
| Income Before Tax | 29.84% | 0.43% | -43.59% | -107.62% | -241.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.84% | 0.43% | -43.59% | -107.62% | -241.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.84% | 0.43% | -43.59% | -107.62% | -241.43% |
| EBIT | 28.70% | 10.56% | -9.99% | -51.31% | -122.13% |
| EBITDA | 28.89% | 10.81% | -9.65% | -51.02% | -121.94% |
| EPS Basic | 29.90% | 0.47% | -43.60% | -102.68% | -216.60% |
| Normalized Basic EPS | 29.93% | 0.49% | -43.54% | -99.52% | -202.24% |
| EPS Diluted | 29.90% | 0.47% | -43.60% | -102.68% | -216.60% |
| Normalized Diluted EPS | 29.93% | 0.49% | -43.54% | -99.52% | -202.24% |
| Average Basic Shares Outstanding | 0.11% | 0.05% | 0.00% | 4.03% | 8.40% |
| Average Diluted Shares Outstanding | 0.11% | 0.05% | 0.00% | 4.03% | 8.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
